- 64% of respondents had seen an increase in their telemedicine consultations since before COVID-19 began
- 68% of respondents started seeing patients virtually because of COVID-19.
ASPS member surgeons formulated the following early predictions on top 2020 procedure trends as in-office visits safely resume for patients, doctors and staff. Insights were gathered from more than 350 members and were based on what members learned from patients via telemedicine appointments.
Injectables were the most asked-for treatments, followed by more invasive procedures.
- Botulinum Toxin Type A - 65%
- Breast Augmentation - 44%
- Soft Tissue Fillers - 37%
- Liposuction - 30%
- Abdominoplasty - 24%
Results show patients continue to be interested in pursuing major surgeries and that the general interest has not changed in the type of procedures and operations from the society's pre-pandemic statistics.
While ASPS anticipates a decrease in total number of cosmetic procedures in 2020 due to the COVID-19 pandemic, the society forecasts a strong demand for treatments as practices reopen for in-office procedures. The number of cosmetic surgical procedures remained steady in 2019 vs. 2018 with 1.8 million surgical procedures performed, and six of the top 10 procedures focused from the neck down.